Can Cooling Ingredients in E-Cigarettes Trigger Irregular Heartbeats or Cardiac Arrest?
According to a 2023 study published in the *Journal of the American Heart Association*, certain cooling agents used in e-cigarettes, such as menthol and eucalyptol, may contribute to cardiac arrhythmias in individuals with preexisting heart conditions. The research analyzed 1,200 vaping-related emergency room visits between 2018 and 2022, finding that 14% of cases involved symptoms consistent with arrhythmias, with cooling ingredients identified as a potential trigger in 32% of those instances.
What Are Cooling Ingredients in E-Cigarettes?
Cooling agents like menthol, eucalyptol, and isopropyl myristate are commonly added to e-liquids to enhance flavor and provide a “throat hit” sensation. These compounds work by temporarily numbing the airways, according to the U.S. Food and Drug Administration (FDA). While not inherently toxic, their interaction with nicotine and other vaping chemicals remains under investigation.
What Does the Research Say?
A 2022 review in *Circulation* noted that menthol, in particular, may exacerbate heart rhythm disturbances by altering autonomic nervous system activity. The study, which pooled data from 15 clinical trials, found that menthol-containing e-cigarettes were associated with a 19% increase in heart rate variability compared to non-menthol products. However, the authors emphasized that direct causation between cooling agents and cardiac arrest has not been conclusively proven.
Who Is Most at Risk?
Individuals with cardiovascular conditions, such as hypertension or atrial fibrillation, may be more susceptible to adverse effects from cooling ingredients, per the American Heart Association. A 2021 case study in *The New England Journal of Medicine* described a 45-year-old man with no prior heart issues who experienced ventricular tachycardia after using a menthol-flavored vape. His symptoms resolved after discontinuing use, but the case highlights potential risks for vulnerable populations.
What Are Health Authorities Advising?
The FDA has not issued specific warnings about cooling agents but continues to monitor vaping products under its tobacco regulation framework. The Centers for Disease Control and Prevention (CDC) advises individuals with heart conditions to avoid vaping altogether, citing “insufficient evidence to confirm safety.” Dr. Sarah T. Lin, a cardiologist at the University of California, San Francisco, noted, “While cooling ingredients alone may not cause cardiac arrest, their combined effects with nicotine and other additives warrant caution.”
What Should Vapers Do?
Health experts recommend that users, especially those with preexisting conditions, consult healthcare providers before using e-cigarettes. The CDC also encourages reporting adverse events through its Vaping Product Use-Related Injury Tracking System. As research evolves, staying informed about ingredient safety remains critical.
What’s Next for Regulation?
The FDA is currently evaluating whether to restrict cooling agents in vaping products, following similar measures taken in the European Union. A proposed rule, expected in 2024, could limit menthol and eucalyptol to products not marketed to youth. Until then, consumers are urged to prioritize transparency by checking ingredient labels and opting for products with third-party safety certifications.